Catalent Reports Second Quarter Fiscal Year 2017 Results Post author:Sam Post published:February 6, 2017 Post category:BioPharma Life Sciences Jobs … Source: BioSpace You Might Also Like Iovance Biotherapeutics Partners With TrakCel For Personalized Patient Product Management September 10, 2017 Bay Area's Pionyr Immunotherapeutics Scores $62M to Push Anti-Tumor Tech Towards Clinic December 12, 2017 Genentech's $94,000-a-Year Drug Tarceva: Why Faster FDA Approvals Could Backfire February 6, 2017
Iovance Biotherapeutics Partners With TrakCel For Personalized Patient Product Management September 10, 2017
Bay Area's Pionyr Immunotherapeutics Scores $62M to Push Anti-Tumor Tech Towards Clinic December 12, 2017